Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr 17;324(5925):392-7.
doi: 10.1126/science.1170540. Epub 2009 Mar 12.

In vivo analysis of dendritic cell development and homeostasis

Kang Liu  1 , Gabriel D Victora, Tanja A Schwickert, Pierre Guermonprez, Matthew M Meredith, Kaihui Yao, Fei-Fan Chu, Gwendalyn J Randolph, Alexander Y Rudensky, Michel Nussenzweig
Affiliations

In vivo analysis of dendritic cell development and homeostasis

Kang Liu et al. Science. .

Abstract

Dendritic cells (DCs) in lymphoid tissue arise from precursors that also produce monocytes and plasmacytoid DCs (pDCs). Where DC and monocyte lineage commitment occurs and the nature of the DC precursor that migrates from the bone marrow to peripheral lymphoid organs are unknown. We show that DC development progresses from the macrophage and DC precursor to common DC precursors that give rise to pDCs and classical spleen DCs (cDCs), but not monocytes, and finally to committed precursors of cDCs (pre-cDCs). Pre-cDCs enter lymph nodes through and migrate along high endothelial venules and later disperse and integrate into the DC network. Further cDC development involves cell division, which is controlled in part by regulatory T cells and fms-like tyrosine kinase receptor-3.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Isolation of pre-cDCs. (A) Presence of MDPs and CDPs in the bone marrow (BM), blood or spleen (SP); not found (NF). (B) Identification of pre-cDCs in bone marrow, LNs, spleen and blood. Bar graph shows the percentage of pre-cDC in each organ. 1×106 cells were acquired per sample. Lin: CD3/CD19/Ter119/NK1.1/B220. (C) Donor-derived spleen cells (CD45.2+) were analyzed for cDC (CD11c+ MHC class II+), pDC (CD11cint B220+) and monocytes (CD11b+ CD11clo/−) 7 days after intravenous injection of 2×106 bone marrow cells or 1×105 pre-cDCs. (D) Analysis of donor-derived splenocytes after transfer with the indicated number of pre-cDCs from bone marrow, spleen and blood. (E) Chimerism in parabiotic mice. In (B) and (C) left side shows representative dot plots. Bar graphs summarize 2-4 independent experiments with 3-4 mice each. Error bars represent the mean ± SEM.
Fig. 2
Fig. 2
Progenitor-product relationship among MDP, CDP and pre-cDC. (A) Phenotype of myeloid progenitor (MP, Lin− Sca-1− c-Kithigh CX3CR1−), MDP (CX3CR1+ c-Kithi) and CDP (CD115+CX3CR1+c-Kitlo) in Cx3cr1gfp/+ mice. (B) Donor-derived bone marrow cells analyzed by flow cytometry for presence of MDPs, CDPs and pre-cDCs two days after intra-bone marrow transfer of 5×104 MPs, MDPs or CDPs. (C) Donor-derived splenocytes analyzed for the presence of cDCs, pDCs and monocytes 7 days after transfer of MDPs or CDPs. (D) EGFP expression in indicated cell populations in LysM-Cre x Rosa26-StopfloxEGFP reporter mice (fig. S8). EGFP index = % of EGFP+ cells / % of EGFP+ Gr1high blood monocytes (20). In (C) and (D) left side shows representative dot plots. Bar graphs summarize 2-4 independent experiments with 3-4 mice. Error bars represent the mean ± SEM.
Fig. 3
Fig. 3
Multi-photon imaging of pre-cDCs. (A) Transferred cells in inguinal LNs 5hrs (upper panel, green) and 6d (lower panel, cyan) after pre-cDC transfer. Panels at right show morphology of transferred pre-cDCs (arrowheads). Scale bars: 1 mm (left) and 30 μm (right). (B) Left: CD62L expression on pre-cDCs. Right: Graph shows number of LN cDCs or migratory DCs (mDCs) after treatment with anti-CD62L. Graph represents the mean ± SD, n=4 mice per group in 3 experiments. * p = 0.0286; ** p < 0.0001, Student’s T test. (C) Dynamic behavior, morphology, and position of pre-cDCs at indicated times. A cell track (yellow) is superimposed to visualize displacement. Scale bar = 50 μm. Far right shows superimposed 2D (XY) tracks with starting coordinates set to the origin. Number of cells analyzed (n) is indicated. (D) Graphs show velocity and confinement of pre-cDCs at indicated times. Differences between columns are significant by Kruskall-Wallis test (heterogeneity: speed, p =0.0006, meandering, p = 0.0055; * p<0.05, ** p<0.01, *** p<0.001, Dunn’s multiple comparison test). All multi-photon data represent at least two independent experiments.
Fig. 4
Fig. 4
Tregs control DC expansion in the peripheral lymphoid organs. (A) Numbers of MDP, pre-cDCs and cDCs in the indicated organs after Treg depletion in Foxp3DTR mice. (B) Pre-cDC and cDC division in spleen and LNs at indicated time after Treg depletion. (C and D) Effect of the Flt3 inhibitor, Sutent, on Treg-depletion induced cDC and B cell expansion. (E) Bar graph shows relative percentage of Flt3−/− CD45.1 and Flt3+/+ CD45.2 DCs and B cells after mixed bone marrow transfer into FoxP3DTR CD45.1XCD45.2 mice after DT treatment. Panels are representative of two-four independent experiments. Bar graph represents the mean ± SEM, n=3-4.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Steinman RM. Nat Med. 2007 Oct;13:1155. - PubMed
    1. Shortman K, Liu YJ. Nat Rev Immunol. 2002 Mar;2:151. - PubMed
    1. Iyoda T, et al. J Exp Med. 2002 May 20;195:1289. - PMC - PubMed
    1. Dudziak D, et al. Science. 2007 Jan 5;315:107. - PubMed
    1. Di Pucchio T, et al. Nat Immunol. 2008 May;9:551. - PMC - PubMed

Publication types

MeSH terms

Substances